Processa Pharmaceuticals, Inc. (PCSA)
NASDAQ·Healthcare·Biotechnology
$2.92
-2.18%
Mkt Cap $6.34M
Analyst Ratings
No recent rating data.
Price Target (1 analysts)
$9.00
Range $9.00 – $9.00
Implied Upside
+208.2%
Consensus $9.00 vs current $2.92
NASDAQ·Healthcare·Biotechnology
$2.92
-2.18%
Mkt Cap $6.34M
No recent rating data.
Price Target (1 analysts)
$9.00
Range $9.00 – $9.00
+208.2%
Consensus $9.00 vs current $2.92